Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation

被引:4
作者
Chalifour, A [1 ]
Roger, J [1 ]
Lemieux, S [1 ]
Duplay, P [1 ]
机构
[1] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada
关键词
D O I
10.1046/j.1365-2567.2003.01618.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The specificity and the relative affinity of many Ly49 receptors for major histocompatibility complex class I ligands have been studied in detail in various adhesion and binding assays. However, how the level of cell surface expression of a given Ly49 receptor and its ligand affinity influence the strength of the inhibition signal is not well documented. To address this issue, we developed a series of human Jurkat T-cell transfectants expressing the whole range of Ly49A and Ly49C levels found in vivo on natural killer and T cells and evaluated their capacity to alter superantigen-induced NF-AT activation and interleukin-2 production. We show that the strength of the inhibition induced by Ly49A/H-2D(d) interaction correlates with Ly49A density up to a certain level after which increasing expression does not further inhibit significantly the T-cell receptor-induced activation. This system also represents a valuable tool for the determination of the relative strength of the inhibitory signals of Ly49 receptors following their interactions with different ligands. Even at high levels of expression there was no evidence that engagement of Ly49A with H-2(b) class I molecules provided an inhibitory signal. Moreover, we showed that functional inhibitory interactions of Ly49C with H-2(b) class I molecules were only the result of H-2K(b) and that H-2(d) represent lower affinity ligands for Ly49C than H-2(b) . Therefore, depending on the relative affinity of Ly49 receptors for their ligands, the modulation of their expression level will be determinant for the functional outcome of activated T cells.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 57 条
[1]   DOMAIN INTERACTIONS OF H-2 CLASS-I ANTIGENS ALTER CYTO-TOXIC T-CELL RECOGNITION SITES [J].
ALLEN, H ;
WRAITH, D ;
PALA, P ;
ASKONAS, B ;
FLAVELL, RA .
NATURE, 1984, 309 (5965) :279-281
[2]   Transgenic expression of Ly49A on T cells impairs a specific antitumor response [J].
Brawand, P ;
Lemonnier, FA ;
MacDonald, HR ;
Cerottini, JC ;
Held, W .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :1871-1876
[3]   Recognition of class I major histocompatibility complex molecules by Ly-49: Specificities and domain interactions [J].
Brennan, J ;
Mahon, G ;
Mager, DL ;
Jefferies, WA ;
Takei, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1553-1559
[4]   EXPRESSION OF DIFFERENT MEMBERS OF THE LY-49 GENE FAMILY DEFINES DISTINCT NATURAL-KILLER-CELL SUBSETS AND CELL-ADHESION PROPERTIES [J].
BRENNAN, J ;
MAGER, D ;
JEFFERIES, W ;
TAKEI, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2287-2295
[5]   Heterogeneity among Ly-49C natural killer (NK) cells: Characterization of highly related receptors with differing functions and expression patterns [J].
Brennan, J ;
Lemieux, S ;
Freeman, JD ;
Mager, DL ;
Takei, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2085-2090
[6]   A novel phosphotyrosine motif with a critical amino acid at position-2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1 [J].
Burshtyn, DN ;
Yang, WT ;
Yi, TL ;
Long, EO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (20) :13066-13072
[7]   Major histocompatibility complex class I-dependent cell binding to isolated Ly-49A: Evidence for high-avidity interaction [J].
Chang, CS ;
Shen, LJ ;
Gong, DE ;
Kane, KP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (12) :3219-3223
[8]  
Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO
[9]  
2-X
[10]   Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets [J].
Depatie, C ;
Chalifour, A ;
Paré, C ;
Lee, SH ;
Vidal, SM ;
Lemieux, S .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (09) :1541-1551